The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

A new COVID-19 vaccine has been approved, but it's not available to everyone. Aerial drone footage shows the humpback whale (Megaptera novaeangliae) missing its iconic lobed fluke, which is ...

FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...